Literature DB >> 2925670

Detection and characterization of a nucleoside transport system in human fibroblast lysosomes.

R L Pisoni1, J G Thoene.   

Abstract

Lysosomes contain enzymatic activities capable of degrading nucleic acids to their constituent nucleosides, but the manner by which these degradation products are released from the lysosome is unknown. To investigate this process, human fibroblast lysosomes, purified on Percoll density gradients, were incubated with [3H]adenosine at pH 7.0, and the amount of adenosine taken up by the lysosomes was measured. Adenosine uptake by fibroblast lysosomes attained a steady state by 12 min at 37 degrees C and was unaffected by the presence of 2 mM MgATP or changes in pH from 5.0 to 8.0. An Arrhenius plot was linear with an activation energy of 12.9 kcal/mol and a Q10 of 2.0. Lysosomal adenosine uptake is saturable, displaying a Km of 9 mM at pH 7.0 and 37 degrees C. Various nucleosides and the nucleobase, 6-dimethylaminopurine, strongly inhibit lysosomal adenosine uptake, whereas neither D-ribose or nucleotide monophosphates have any significant effect upon lysosomal adenosine uptake. On a molar basis, purines are recognized more strongly than pyrimidines. Changing the nature of the nucleoside sugar from ribose to arabinose or deoxyribose has little effect on reactivity with this transport system. The known plasma membrane nucleoside transport inhibitors, dipyridamole and nitrobenzylthioinosine, inhibit lysosomal nucleoside transport at relatively low concentrations (25 microM) relative to the Km of 9 mM for lysosomal adenosine uptake. The half-times of [3H]inosine and [3H]uridine efflux from fibroblast lysosomes ranged from 6 to 8 min at 37 degrees C. Trans effects were not observed to be associated with either inosine or uridine exodus. In contrast to adenosine uptake, adenine primarily enters fibroblast lysosomes by a route not saturable by high concentrations of various nucleosides. In conclusion, the saturability of lysosomal adenosine uptake and its specific, competitive inhibition by other nucleosides indicate the existence of a carrier-mediated transport system for nucleosides within fibroblast lysosomal membranes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2925670

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Inhibition of Transient Receptor Potential Channel Mucolipin-1 (TRPML1) by Lysosomal Adenosine Involved in Severe Combined Immunodeficiency Diseases.

Authors:  Xi Zoë Zhong; Yuanjie Zou; Xue Sun; Gaofeng Dong; Qi Cao; Aditya Pandey; Jan K Rainey; Xiaojuan Zhu; Xian-Ping Dong
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

2.  Intracellular localization of p40, a protein identified in a preparation of lysosomal membranes.

Authors:  Marielle Boonen; Isabelle Hamer; Muriel Boussac; Anne-Françoise Delsaute; Bruno Flamion; Jérôme Garin; Michel Jadot
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 3.  Molecular physiology and pathophysiology of lysosomal membrane transporters.

Authors:  C Sagné; B Gasnier
Journal:  J Inherit Metab Dis       Date:  2008-04-15       Impact factor: 4.982

4.  Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.

Authors:  R L de Vrueh; E T Rump; E van De Bilt; R van Veghel; J Balzarini; E A Biessen; T J van Berkel; M K Bijsterbosch
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Demonstration of adenosine deaminase activity in human fibroblast lysosomes.

Authors:  E R Lindley; R L Pisoni
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

6.  Functional reconstitution of the lysosomal sialic acid carrier into proteoliposomes.

Authors:  G M Mancini; C E Beerens; H Galjaard; F W Verheijen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

7.  Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.

Authors:  Meaghan Stolk; Elizabeth Cooper; Greg Vilk; David W Litchfield; James R Hammond
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 8.  Lysosomal transport disorders.

Authors:  G M Mancini; A C Havelaar; F W Verheijen
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

9.  Defective glucuronic acid transport from lysosomes of infantile free sialic acid storage disease fibroblasts.

Authors:  H J Blom; H C Andersson; R Seppala; F Tietze; W A Gahl
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

10.  Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.

Authors:  Kristie D Ibarra; Julie K Pfeiffer
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.